Erectile Dysfunction in High‐Risk Hypertensive Patients Treated with Beta‐Blockade Agents

Abstract

ED is highly prevalent in hypertensive patients treated with beta-blockade agents. The presence of ED is associated with more extended organ damage and not to cardiovascular treatments, except for the lower prevalence in nebivolol-treated patients.